Parental Subsidies for Diagnostics
Executive Summary
Wrapped in a modish genomic gown, in vitro diagnostics are back in fashion. No sooner has Applera (formerly PE Corp.) announced a major new initiative in diagnostics than diaDexus files for an IPO. But these aren't your grandfather's diagnostics companies: they start life with huge pharmaceutical subsidies in terms of genomic data and financing.